Emerging Therapy Solutions® (ETS) was founded in 2018 by industry veterans of managed care solutions, healthcare biotech and transplant to help healthcare payers manage the risks associated with high-cost therapies for rare and complex conditions. ETS acquired LifeTrac in 2020, bringing over 30 years of experience in bone marrow and solid organ transplants, plus provider relationships and agreements, to complement Emerging Therapy Solutions’ expertise in cell and gene therapies. The integrated business offers payers a comprehensive suite of services for solid organ and bone marrow transplants, cell and gene therapies, and other highly specialized therapies.